Exosomes In Stroke Management: A Promising Paradigm Shift In Stroke Therapy

The document explores the potential of exosomes as a promising therapeutic approach for stroke management, emphasizing their ability to cross the blood-brain barrier and modulate intracellular signaling in neurons. Exosomes, particularly those derived from mesenchymal stem cells, have shown efficacy in preclinical studies for promoting neural regeneration, reducing neuroinflammation, and protecting against oxidative stress. They can deliver therapeutic agents, such as proteins and microRNAs, to ischemic regions, aiding in tissue repair and recovery. Despite these promising findings, challenges remain in translating these results into clinical practice due to limited sample sizes, safety concerns, and ethical considerations. The review calls for extensive preclinical research and future randomized controlled trials to establish the safety and efficacy of exosome therapy, which could lead to large-scale clinical applications in stroke treatment.